The company will challenge Medtronic’s IN.PACT Admiral device to treat peripheral arterial disease with a balloon that is coated with a lower dose of paclitaxel.
The company will challenge Medtronic’s IN.PACT Admiral device to treat peripheral arterial disease with a balloon that is coated with a lower dose of paclitaxel.